SCHEMBL18894097

SCHEMBL18894097

Cc1c(F)c(OC(F)F)cc2[nH][c]nc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2969991 0.64 DHODH (0.31) —
SCHEMBL18894120 0.63 — —
SCHEMBL6883568 0.62 CCNB2 (0.34) —
SCHEMBL3648817 0.59 HSD17B10 (0.35) —
SCHEMBL11602680 0.58 AMY1A (0.35) —
SCHEMBL9562029 0.56 KMT2A (0.33) —
SCHEMBL14033406 0.56 KMT2A (0.36) —
SCHEMBL17991846 0.56 ALDH1A1 (0.39) —
SCHEMBL900934 0.56 BACE1 (0.43) —
SCHEMBL25974309 0.56 PDE2A (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11136310-B2 Iminotetrahydropyrimidinone derivatives as plasmepsin V inhibitors UCB Biopharma SRL (BE) 2021-10-05 — — US disclosed
US-20200283416-A1 IMINOTETRAHYDROPYRIMIDINONE DERIVATIVES AS PLASMEPSIN V INHIBITORS CELLTECH R&D LIMITED (GB) 2020-09-10 — — US disclosed
EP-3380464-A1 IMINOTETRAHYDROPYRIMIDINONE DERIVATIVES AS PLASMEPSIN V INHIBITORS UCB Biopharma SPRL (BE) 2018-10-03 — — EP disclosed
WO-2017089453-A1 IMINOTETRAHYDROPYRIMIDINONE DERIVATIVES AS PLASMEPSIN V INHIBITORS UCB BIOPHARMA SPRL (BE) 2017-06-01 — — WO disclosed
Send feedback